Research Avenue A: Developing and testing new models for resilient health systems, particularly related to primary care
- Supporting cost effective, accessible health systems, including policy frameworks, infrastructure, information technology, and workforce capacity, particularly in fragile or crisis affected contexts.
- Strengthening of primary care, trauma, and emergency medical services that improves equity and access to treatment for vulnerable and underserved populations, particularly mothers, children, and adolescents.
- Innovation in health financing and public health insurance models, including public–private partnerships, that promotes sustainable and equitable health system funding and patient access.
- Integrating insights from health determining sectors and the social determinants of health to address mental health, malnutrition, or other non communicable diseases that place strain on health systems.
Research Avenue B: One Health preparedness and infectious disease surveillance
- Strengthening integrated One Health surveillance and diagnostic systems through coordinated use of human, animal, or environmental data to improve early warning, detection, and response to emerging diseases.
- Application of AI driven surveillance and predictive modelling technologies that improves preparedness for zoonotic and/or climate linked health threats.
- Supporting prediction of emerging and re emerging diseases and strengthens pandemic preparedness at transboundary or regional levels, taking explicitly into account the context of climate change impacts.
- Integrating interdisciplinary insights related to agriculture, food security and the environment, and/or elements of traditional knowledge to support a holistic approach to One Health.
Research Avenue C: Exploring the use of traditional knowledge to combat communicable and non communicable diseases
- Improving, harmonizing, and strengthening pharmacopoeia systems, focusing on the quality, safety, and efficacy of traditional medicines through meta-analyses and new guidance.
- Development, promotion, and scaling of traditional therapeutic products and approaches at multi country or regional levels to address communicable diseases, non communicable diseases, and trauma or injuries, as well as mental health.
- Biodiversity based research, including bioprospecting and genomics, that contributes to health objectives through the development of new compounds.
